elsevier cancer moonshot infographic

1
Cancer Research: Current Trends & Future Directions Cancer is the leading cause of premature death in 28 European countries and across the United States 1 Globally, the US leads with the largest shares of institutions, publication volume, and patent level citations in cancer research. US 0.32 Canada 0.26 France 0.22 Germany 0.28 UK 0.25 Italy 0.22 China 0.13 Japan 0.17 2010 Patent Citations Per Publication US 34,674 Canada 4,653 France 5,023 Germany 6,540 UK 7,122 Italy 6,011 China 20,505 Japan 8,001 2014 Publication Output 2005-2014 Institution Output 19,811 17,115 Harvard University University of Texas MD Anderson Cancer Center National Institutes of Health Memorial Sloan-Kettering Cancer Center Johns Hopkins University University of California at San Francisco Dana Farber Cancer Institute University of Toronto University of Michigan Mayo Clinic Rochester MN 16,172 10,049 10,075 6,917 4,643 9,925 7,144 5,483 The critical mass of cancer research globally remains situated in the US 1 Leading causes of death in US & Europe: fact sheet, WHO Europe. http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf 2 Reference http://stats.oecd.org/Index.aspx?DataSetCode=MSTI_PUB# China has dramatically increased publication output in cancer research and today commands over 17% of the global share of publications, up from around 5% a decade ago. China has benefited from a rise in research and development expenditure (as a share of GDP) and a shiſt from socialist economic planning to a more market driven system over the past decade. Some countries such as Germany, the UK, and most noticeably China, show a general increase in impact over the period 2005–2014. The US displays a relatively static performance. US 2005 China 2014 20,505 20,314 In 2014, China produced as many papers as the US did in 2005. China’s Gross Expenditures For R&D as Share of GDP 1991-2010 2 0.0 0.5 1.0 1.5 2.0 1991 1995 2000 2005 2010 Field-Weighted Citation Impact for Cancer Research China has increased its FWCI over the past decade 0 0.5 1.0 1.5 2.0 2.5 2005 2014 2006 2007 2008 2009 2010 2011 2012 2013 World average (= 1.0) US China Japan UK Germany Italy Canada France Source: Scopus

Upload: elsevier

Post on 07-Jan-2017

5.823 views

Category:

Health & Medicine


2 download

TRANSCRIPT

Page 1: Elsevier Cancer Moonshot Infographic

Cancer Research: Current Trends & Future DirectionsCancer is the leading cause of premature death in 28 European countries and across the United States1

Globally, the US leads with the largest shares of institutions, publication volume, and patent level citations in cancer research.

US0.32

Canad

a

0.26

France0.22

Germany0.28

UK0.25

Italy0.22

China0.13

Japan0.17

2010 Patent Citations Per Publication

US34,674

Canad

a

4,653

France5,023

Germany6,540

UK

7,122

Italy6,011

China20,505

Japan8,001

2014 Publication Output

2005-2014 Institution Output

19,811

17,115

Harvard University

University of Texas MD Anderson Cancer Center

National Institutes of Health

Memorial Sloan-Kettering Cancer Center

Johns Hopkins University

University of California at San Francisco

Dana Farber Cancer Institute

University of Toronto

University of Michigan

Mayo Clinic Rochester MN

16,172

10,049

10,075

6,917

4,643

9,925

7,144

5,483

The critical mass of cancer research globally remains situated in the US

1 Leading causes of death in US & Europe: fact sheet, WHO Europe.http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf

2 Reference http://stats.oecd.org/Index.aspx?DataSetCode=MSTI_PUB#

China has dramatically increased publication output in cancer research and today commands over 17% of the global share of publications, up from around 5% a decade ago.

China has bene�ted from a rise in research and development expenditure (as a share of GDP) and a shi� from socialist economic planning to a more market driven system over the past decade.

Some countries such as Germany, the UK, and most noticeably China, show a general increase in impact over the period 2005–2014. The US displays a relatively static performance.

US 2005 China 2014

20,505

20,314

In 2014, China produced as many papers as the US did in 2005.

China’s Gross Expenditures For R&D as Share of GDP 1991-20102

0.0

0.5

1.0

1.5

2.0

1991 1995 2000 2005 2010

Field-Weighted Citation Impact for Cancer Research

China has increased its FWCI over the past decade

0

0.5

1.0

1.5

2.0

2.5

2005 20142006 2007 2008 2009 2010 2011 2012 2013

World average (= 1.0)

US

China

Japan

UK

Germany

Italy

Canada

France

Source: Scopus